Vontobel Holding
PACB icon

Vontobel Holding’s Pacific Biosciences PACB Stock Holding History

Vontobel Holding’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,362
Closed -$47K – 1087
2022
Q2 		$47K Sell
10,362
-105,283
-91% -$640K ﹤0.01% 1000
2022
Q1 		$1.12M Buy
115,645
+23,693
+26% +$273K 0.01% 585
2021
Q4 		$1.92M Buy
91,952
+17,238
+23% +$416K 0.02% 447
2021
Q3 		$1.91M Buy
74,714
+5,583
+8% +$165K 0.02% 451
2021
Q2 		$2.49M Buy
69,131
+33,731
+95% +$981K 0.02% 393
2021
Q1 		$1.18M Buy
+35,400
New +$1.24M 0.01% 494

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vontobel Holding's PACB Position: Q3 2022 in Review

Vontobel Holding sold out of Pacific Biosciences (PACB) in Q3 2022, closing a stake of 10,362 shares — an estimated $47K sold.

Vontobel Holding first reported a position in PACB in Q1 2021 and held it in 6 quarters. The position peaked at $2.49M in Q2 2021. 227 funds tracked by Wall St. Rank hold PACB as of Q3 2022.

  • Vontobel Holding reported no remaining Pacific Biosciences position as of Q3 2022 after selling out during the quarter.
  • Vontobel Holding sold 10,362 Pacific Biosciences shares in Q3 2022, an estimated $47K.
  • Vontobel Holding first reported a position in Pacific Biosciences in Q1 2021 and held it in 6 quarters.
  • Vontobel Holding's Pacific Biosciences position peaked at $2.49M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2022.

Based on Vontobel Holding's 13F filing for Q3 2022, filed 4 Nov 2022.